The city of Tulsa, Oklahoma, currently has 1 active clinical trials seeking participants for Alzheimer's Disease research studies.
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
Recruiting
This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.
Gender:
ALL
Ages:
Between 50 years and 85 years
Trial Updated:
11/21/2024
Locations: Central States Research, LLC, Tulsa, Oklahoma
Conditions: Early Alzheimer's Disease